Your gift can also support the Richard J. Meyer Endowed Lectureship, bringing cutting‑edge scientific insights to LCID faculty, students, and postdoctoral fellows. Give today: www.givecampus.com/s/9jdc55 #UT40for40
LaMontagne Center for Infectious Disease
@lcidatut.bsky.social
Official account for the LaMontagne Center for Infectious Disease at the University of Texas at Austin. Specializing in infectious disease research. Website: lcid.utexas.edu
It’s the final day of #UT40for40! LCID research is shaping the prevention and treatment of infectious diseases worldwide. Join us and give today. www.givecampus.com/s/9jdc55
LCID members bring expertise across 30+ infectious diseases, studying viral and bacterial mutations, antibiotic resistance, biotechnology, biofilms, nanomedicine, and vaccines. Help advance this vital research today: www.givecampus.com/s/9jdc55 #UT40for40
UT's 40 Hours for the Forty Acres campaign starts today! The time to give is NOW to support the LaMontagne Center for Infectious Disease and the important work its researchers do! www.givecampus.com/s/9jdc55 #UT40for40
We are less than a week away from our 40 Hours for the Forty Acres annual fundraising event on April 29-30, 2026. Help us change the world by supporting our infectious disease research! www.givecampus.com/s/9jdc55 #UT40for40
The Davies Lab has uncovered a surprising new role for microcins. Known for killing competing bacteria, these proteins can also form amyloid fibers that help build biofilms—revealing a dual life as both toxin and structural support. See: lcid.utexas.edu/news/researc...
The Bayer-Santos Lab, along with researchers at the University of São Paulo, have discovered salmonella toxins that could lead to healthier microbiomes and new targetted antibacterial therapies. See: cns.utexas.edu/news/researc...
A Secret Weapon from Salmonella Could Help Us Maintain Healthier Microbiomes
The discovery could also lend itself to the development of future antibacterial therapies.
cns.utexas.edu
Hantaviruses kill nearly 40% of those infected and there’s no approved treatment or vaccine, making them a concern for future pandemics. The most detailed 3D map yet of a key protein complex on the virus might yield new treatments. cns.utexas.edu/news/researc...
A Step Towards Needed Treatments for Hantaviruses in New Molecular Map
An innovative imaging technique enabled dramatically higher resolution structures than previous efforts.
cns.utexas.edu
A new approach called “epimodulation” — developed by UT Austin researchers & collaborators — predicts epidemic peaks better than current models and could boost health care preparations in future outbreaks. #Epidemiology #PublicHealth @texas-ib.bsky.social cns.utexas.edu/news/researc...
A New Tool for Healthcare Gives Better Outbreak Forecasts
Pinpointing an outbreak’s peak, the approach can boost health systems’ preparedness and risk communication.
cns.utexas.edu
Researchers in the Davies Lab at UT and NIH reveal the first high-res structure of a microcin binding its bacterial receptor—offering more insight in fighting drug-resistant infections. Learn more: lcid.utexas.edu/news/researc...
High-Resolution Structure Reveals How Microcins Target Bacteria
High-Resolution Structure Reveals How Microcins Target Bacteria
lcid.utexas.edu
Congratulations to LCID member Dr. Jason McLellan on receiving a 2025 MacArthur Fellowship for his groundbreaking work in structural biology and infectious disease interventions! cns.utexas.edu/news/accolad...
Virus Slayer Awarded ‘Genius Grant’ by MacArthur Foundation
The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.
cns.utexas.edu
LCID member Dr. Bryan Davies and his lab have found a new method to help antibodies kill bacteria. Their paper in the journal PNAS describes how: lcid.utexas.edu/news/researc...
Re-engineered Antibodies Kill Bacteria Directly
These antibodies use a clever trick to slip deep into a bacteria's outer membrane, where they can do real damage.
lcid.utexas.edu
SAVE THE DATE: Dr. Vincent Young, MD, PhD, to present the 2025 Richard Meyer Lecture on Nov. 11. lcid.utexas.edu/events/vince...
Vincent Young at the 2025 Richard J. Meyer Lecture
Dr. Vincent Young, professor at the University of Michigan Medical School will present the 2025 Richard J. Meyer Lecture.
lcid.utexas.edu
Recently published article from the Davies Lab shows wide diversity of microcins that may one day aid in the fight against antibiotic resistance.
A set of weapons bacteria use to fight each other, called microcins, are much more widespread and diverse than previously thought. They might inspire new ways to combat antibiotic resistant bacteria. Learn more in Nature Communications: rdcu.be/eumkH
Dr. Grace Kago, researcher in the Payne Lab, recently had her e-learning community that translates science into Kikuyu, a Central Kenyan language, included in UNESCO’s Open and Inclusive Science Hub. For more, see lcid.utexas.edu/news/announc...